Pharmacokinetic study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old with Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)

Exclusion Criteria

• - Use of any other investigational compound or participation in another clinical trial within 28 days prior to the screening visit.
• - History or presence of gastrointestinal, hepatic or renal disease or other conditions that could interfere with absorption, distribution, metabolism or excretion of esomeprazole.
• - Unstable diabetes mellitus or history of seizure disorder.
• - Any acute or chronic illness or a medical history, which in the opinion of the investigator and/or sponsor, could compromise the patient’s safety or successful participation in the study.